MA
Insider
Mario Alberto Accardi
President, Orexin ProgramMario Alberto Accardi (President, Orexin Program) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Centessa Pharmaceuticals plc (CNTA). The largest single filing was $300K of CNTA (10,000 sh × $30.00, as filed), executed Dec 8 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$713K
shares × price, as filed
Last traded
Dec 9 2025
Filed Dec 9 2025
Median ADV $76.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
CNTA
Centessa Pharmaceuticals plc
CNTA · 0 buys · 7 sells
7 filings
Recent filings
CNTASALE
Centessa Pharmaceuticals plc
View filing →
$213K7,432 sh × $28.70
Exec Dec 9 2025
Filed Dec 9 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $300K
10,000 sh × $30.00
Exec Dec 8 2025
Filed Dec 8 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $200K
8,000 sh × $25.00
Exec Oct 27 2025
Filed Oct 27 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $158K
7,430 sh × $21.33
Exec Sep 16 2025
Filed Sep 16 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $140K
7,000 sh × $20.00
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $127K
8,322 sh × $15.23
Exec Jul 29 2025
Filed Jul 30 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $210K
15,000 sh × $14.00
Exec Jun 24 2025
Filed Jun 25 2025 · 5:30 PM ET